Scheiner Zachary

LENZ Therapeutics, Inc. · Director

Scheiner Zachary is listed in filings as Director at LENZ Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 11, 2025, including 3 public disclosures. Recent filings connect the profile to LENZ Therapeutics, Inc. (LENZ) and Nkarta, Inc. (NKTX). The current snapshot covers public activity from Jun 14, 2024 to Jun 11, 2025. Reported amounts are shown as $405.0K to $140.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.